Stock Comparison
ONC vs VRTX
BeiGene, Ltd. and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$39.07B
$123.94B
P/E (TTM)
61.6
28.5
Forward P/E
51.1
25.7
Price/Sales
6.4
9.9
Price/Book
7.6
6.1
EV/EBITDA
32.6
23.2
Dividend Yield
—
—
Profitability
Net Margin
8.94%
35.40%
Operating Margin
11.95%
38.97%
Return on Equity
14.70%
23.50%
Return on Assets
7.46%
11.90%
Growth (YoY)
Revenue Growth
29.60%
12.50%
Earnings Growth
166.70%
8.00%
Price & Risk
Beta
0.5
0.3
52-Week High
$377.47
$529.65
52-Week Low
$260.27
$376.62
Analyst Target
$431.34
$559.28
Compare ONC and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.